MicroStrategy Shifts STRC to Semi-Monthly Dividends as Daily Trading Volume Hits $1.1B

BTC-0.05%

Gate News message, April 18 — MicroStrategy announced plans to switch its Variable Rate Series A Perpetual Stretch Preferred Stock (STRC) from monthly to semi-monthly dividend payouts. The company stated the change would reduce the interval between payouts, allowing investors to compound gains faster, stabilize stock prices, and attract more capital. Founder Michael Saylor emphasized on X that the updated cadence would "stabilize price, dampen cyclicality, drive liquidity, and grow demand" without altering the current 11.5% annual payout rate. Shareholders are scheduled to vote on the proposal by June 8.

STRC has gained significant momentum. On April 13, daily trading volume reached $1.1 billion, a new record. The preferred stock's total market value has climbed to $6.4 billion, with volatility dropping to 2.1% over the past two months from 13% in the first eight months after launch. Earlier this week, MicroStrategy purchased 13,927 BTC for approximately $1 billion, bringing total holdings to 780,897 BTC, largely financed through the sale of over 10 million STRC shares.

On Friday, MicroStrategy shares surged 11.8% as Bitcoin climbed 3% to $77,400—its highest level since mid-January—following reports that Iran's foreign minister assured cargo ships could pass through the Strait of Hormuz without incident during a 10-day truce. The company had faced significant pressure, with its stock declining 42% from a $279 peak over the past six months.

Analysts note that while the ceasefire provided short-term relief, underlying challenges remain. The company's large Bitcoin holdings give it outsized market influence, and the dividend structure has created substantial cost burdens.

Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments